Brief: Oncolytics Biotech® Announces Favourable Aware-1 Safety Update

Oncolytics Biotech

24/03/2020 12:38

March 24 (Reuters) - Oncolytics Biotech Inc  ONC.TO :
    * ONCOLYTICS BIOTECH® ANNOUNCES FAVOURABLE AWARE-1 SAFETY
UPDATE
    * ONCOLYTICS BIOTECH - COHORT 1 SHOWED WIDESPREAD VIRAL
REPLICATION IN MAJORITY TUMORS WITH CREATION OF PRO-INFLAMMATORY
EFFECT IN TUMOR MICROENVIRONMENT
    * ONCOLYTICS BIOTECH INC - NO NEGATIVE EFFECTS TO HEALTHY
TISSUE
WERE NOTED IN STUDY
    * ONCOLYTICS BIOTECH - SAFETY COMMITTEE APPROVED AMENDMENT
OF
STUDY TO LOWER DOSE OF TECENTRIQ TO BE CURRENTLY APPROVED BREAST
CANCER DOSE OF 840MG
    * ONCOLYTICS BIOTECH INC - STUDY WILL CONTINUE TO ENROLL
PATIENTS

Source text for Eikon:  ID:nCNWXkFMFa 
Further company coverage:  ONC.TO 

 ((Reuters.Briefs@thomsonreuters.com;))